<DOC>
	<DOCNO>NCT00964236</DOCNO>
	<brief_summary>The objective study determine whether Kuvan™ ( sapropterin ) improve strength functional connectivity brain region individual PKU .</brief_summary>
	<brief_title>The Effects Kuvan Functional Brain Connectivity Individuals With Phenylketonuria ( PKU )</brief_title>
	<detailed_description>The propose study design evaluate hypothesis functional connectivity may represent early marker neurocognitive improvement related Kuvan treatment . As first step study , 20 patient PKU ≥ 6 year age receive baseline functional connectivity magnetic resonance imaging ( fcMRI ) evaluation treat Kuvan™ . Response Kuvan™ monitor 4 week . At end 4 week , response Kuvan™ review 20 patient receive follow-up fcMRI evaluation . Fifteen patient reduction ≥ 20 % blood phenylalanine continue study receive third fcMRI evaluation end 6 month treatment Kuvan™ . For comparison purpose control possible practice effect repeat test , match control group 20 healthy individual without PKU use . All 20 control subject receive baseline 4-week fcMRI evaluation ; fifteen receive 6-month evaluation .</detailed_description>
	<mesh_term>Phenylketonurias</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<criteria>Willing able provide inform consent assent . Willing able comply study procedure . Greater equal 6 year age . For phenylketonuria , intention physician prescribe sapropterin . For phenylketonuria , phenylalanine level great equal 300μmol/L . For phenylketonuria , negative pregnancy test childbearing potential . For phenylketonuria , willing use contraception sexually active . Pregnant , breastfeeding , plan become pregnant study . Use investigational product le 30 day prior study . Concurrent condition could interfere participation safety . Any condition create high risk poor compliance study . Perceived unreliable unavailable study . Use LDopa , methotrexate , drug inhibit folate metabolism . For phenylketonuria , know hypersensitivity sapropterin excipients .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>sapropterin</keyword>
	<keyword>Kuvan</keyword>
	<keyword>cognition</keyword>
	<keyword>brain</keyword>
</DOC>